TBUFF Financials 07/16/2014 08:43:35 Tribute Phar

TBUFF Financials 07/16/2014 08:43:35
Tribute Pharmaceuticals Canada Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 12,650 12,396 3,801 4,768
Cost of Revenue 7,005 7,205 1,417 1,150
Gross Profit 5,644 5,191 2,383 3,618
Operating Expenses
Research and Development - - - -
Sales, General and Admin. 9,252 8,909 2,980 2,504
Non-Recurring Items - - - -
Other 1,173 722 77 50
Operating Income (4,780) (4,440) (674) 1,064
Income From Continuing Operations
Add'l Income/Expense Items (1,206) 45 (798) (534)
Earnings Before Interest and Tax (5,986) (4,395) (1,472) 529
Interest Expense 496 254 - -
Earnings Before Tax (6,482) (4,649) (1,472) 529
Income Tax (296) (1,286) (959) -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (6,770) (3,363) (512) 529
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (6,186) (3,363) (512) 529
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (6,186) (3,363) (512) 529